Inhibition of platelet function by a controlled release acetylsalicylic acid formulation — Single and chronic dosing studies
- 1 September 1984
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 27 (1) , 67-74
- https://doi.org/10.1007/bf02395209
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Prostacyclin is not a circulating hormone in manProstaglandins, 1982
- Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase evidence from ‘in vivo’ drug interaction studies in ratsBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.Stroke, 1980
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962